MedTrace Logo

Evaluating the Coordinated National Implementation of DBT in Ireland

NCT03180541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2018-07-03

No results posted yet for this study

Summary

This study aims to evaluate the coordinated implementation of Dialectical Behaviour Therapy in Community Mental Health Services in Ireland.

There are three main objectives of the current study:

* evaluate the effectiveness of DBT for adults and adolescents attending Community Mental Health Services in multiple sites across Ireland
* conduct an economic evaluation of the coordinated implementation of DBT in community settings in Ireland
* evaluate the implementation initiative by means of quantity, quality and experience of the coordinated implementation

Conditions

  • Personality Disorder, Borderline

Interventions

BEHAVIORAL

Dialectical Behaviour Therapy

Dialectical Behaviour Therapy (DBT) is a psychological intervention which was originally developed for women with Borderline Personality Disorder. DBT is delivered by a team of multidisciplinary mental health professionals, and comprises of individual therapy sessions for each patient, group skills training sessions, phone coaching and consultation meetings for the clinicians on the DBT team. Group skills are delivered in blocks of three modules which teach mindfulness, distress tolerance, emotion regulation and interpersonal effectiveness. The three modules are delivered over a 24-week period and are then repeated.

Sponsors & Collaborators

  • Health Service Executive, Ireland

    lead OTHER

Principal Investigators

  • Daniel Flynn, Prof. Dip · Psychology Manager

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-09-30
Completion
2018-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03180541 on ClinicalTrials.gov